X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (667) 667
Book Review (70) 70
Conference Proceeding (60) 60
Publication (29) 29
Book Chapter (4) 4
Book / eBook (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (374) 374
index medicus (371) 371
pulmonary hypertension (241) 241
respiratory system (237) 237
female (236) 236
male (229) 229
middle aged (201) 201
adult (176) 176
abridged index medicus (174) 174
hypertension, pulmonary - physiopathology (134) 134
hypertension, pulmonary - drug therapy (129) 129
aged (113) 113
cardiac & cardiovascular systems (98) 98
hypertension (95) 95
treatment outcome (90) 90
pulmonary arterial hypertension (88) 88
survival (84) 84
hypertension, pulmonary - diagnosis (83) 83
arterial-hypertension (78) 78
hypertension, pulmonary - etiology (77) 77
diagnosis (71) 71
risk factors (69) 69
critical care medicine (67) 67
therapy (67) 67
care and treatment (62) 62
prognosis (57) 57
hemodynamics (56) 56
retrospective studies (55) 55
research (51) 51
drug therapy (50) 50
antihypertensive agents - therapeutic use (49) 49
pulmonary arteries (47) 47
hypertension, pulmonary - mortality (45) 45
medicine, general & internal (45) 45
hypertension, pulmonary - therapy (44) 44
bosentan (43) 43
disease (43) 43
adolescent (42) 42
life sciences (42) 42
animals (41) 41
prostacyclin (40) 40
hypertension, pulmonary (39) 39
double-blind method (37) 37
hypertension, pulmonary - epidemiology (37) 37
chronic disease (36) 36
prospective studies (36) 36
mortality (34) 34
mutation (34) 34
surgery (33) 33
familial primary pulmonary hypertension (32) 32
follow-up studies (32) 32
peripheral vascular disease (32) 32
hypertension, pulmonary - genetics (31) 31
endothelin (30) 30
endothelin receptor antagonists (30) 30
lung transplantation (30) 30
young adult (30) 30
calcium-channel blockers (29) 29
health aspects (29) 29
pulmonary/respiratory (29) 29
sildenafil (29) 29
time factors (29) 29
analysis (28) 28
expression (28) 28
case-control studies (27) 27
endarterectomy (27) 27
guidelines (27) 27
double-blind (26) 26
drug therapy, combination (26) 26
epoprostenol (26) 26
heart (26) 26
hypertension, pulmonary - pathology (26) 26
transplantation (26) 26
continuous intravenous epoprostenol (25) 25
registry (25) 25
antihypertensive agents - administration & dosage (24) 24
cardiovascular (24) 24
hypertension, pulmonary - complications (24) 24
patients (24) 24
pulmonary artery - physiopathology (24) 24
registries (24) 24
severity of illness index (24) 24
clinical trials (23) 23
france - epidemiology (23) 23
lung (23) 23
pulmonary embolism (23) 23
aged, 80 and over (22) 22
cardiac catheterization (22) 22
disease progression (22) 22
human health and pathology (22) 22
hypertension, pulmonary - surgery (22) 22
rats (22) 22
sulfonamides - therapeutic use (22) 22
bone morphogenetic protein receptors, type ii - genetics (21) 21
survival rate (21) 21
algorithms (20) 20
pulmonary embolism - diagnosis (20) 20
antihypertensive agents - adverse effects (19) 19
cardiology and cardiovascular medicine (19) 19
epoprostenol - administration & dosage (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 26, pp. 2522 - 2533
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 05/2018, Volume 197, Issue 10, pp. 1364 - 1365
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 05/2018, Volume 197, Issue 10, pp. 1364 - 1365
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a... 
INHALED ILOPROST | SURVIVAL | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EPOPROSTENOL | COMBINATION THERAPY | HEART-FAILURE | DOUBLE-BLIND | BOSENTAN | Hypertension, Pulmonary - mortality | Double-Blind Method | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Hypertension, Pulmonary - physiopathology | Male | Hospitalization | Disease Progression | Tadalafil | Phenylpropionates - therapeutic use | Peptide Fragments - blood | Adult | Female | Phenylpropionates - adverse effects | Aged | Hypertension, Pulmonary - drug therapy | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Natriuretic Peptide, Brain - blood | Pyridazines - adverse effects | Pyridazines - therapeutic use | Symptomatology | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan | Hypertension | Edema | Brain natriuretic peptide | Headache | Functional morphology | Pulmonary arteries | Lung diseases | Drug therapy | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus | Drug side effects | Assaigs clínics de medicaments | Efectes secundaris dels medicaments | Hipertensió pulmonar | Drug testing | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 10/2008, Volume 149, Issue 8, pp. 521 - 530
Background: Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension.... 
INHALED ILOPROST | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ORAL SILDENAFIL | EFFICACY | TREPROSTINIL | SAFETY | COMBINATION THERAPY | PROSTACYCLIN | BOSENTAN | Piperazines - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Sulfones - adverse effects | Antihypertensive Agents - administration & dosage | Hypertension, Pulmonary - physiopathology | Male | Dyspepsia - chemically induced | Purines - administration & dosage | Hemodynamics - physiology | Walking - physiology | Sildenafil Citrate | Time Factors | Epoprostenol - adverse effects | Adult | Female | Hypertension, Pulmonary - drug therapy | Purines - adverse effects | Drug Therapy, Combination | Headache - chemically induced | Double-Blind Method | Administration, Oral | Piperazines - adverse effects | Antihypertensive Agents - adverse effects | Adolescent | Quality of Life | Aged | Vasodilator Agents - adverse effects | Hypertension, Pulmonary - etiology | Vasodilator Agents - administration & dosage | Epoprostenol - administration & dosage | Sulfones - administration & dosage | Complications and side effects | Epoprostenol | Dosage and administration | Sildenafil | Drug therapy, Combination | Research | Drug therapy | Pulmonary hypertension | Hypertension | Inhibitor drugs | Patients | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 167, Issue 2, pp. 210 - 217
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 09/2016, Volume 126, Issue 9, pp. 3207 - 3218
Journal Article
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, ISSN 1073-449X, 03/2018, Volume 197, Issue 6, pp. 704 - 706
In this issue of the Journal, Zamanian and colleagues (pp. 788-800) present the results from a prospective cohort study of patients with pulmonary arterial... 
METHAMPHETAMINE | FENFLURAMINE DERIVATIVES | RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Drugs | Anorexia | Methamphetamines | Pulmonary arteries | Medical prognosis | Mutation | Health risk assessment | Pulmonary hypertension
Journal Article
2012, Progress in respiratory research, ISBN 9783805599153, Volume 41.
Web Resource
Annals of the Rheumatic Diseases, ISSN 0003-4967, 07/2017, Volume 76, Issue 7, pp. 1219 - 1227
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2005, Volume 46, Issue 3, pp. 529 - 535
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 9, pp. 809 - 818
Journal Article